Zepp Health Corporation - ZEPP EV/Sales Multiple

Public company logo of Huami Corporation (ZEPP)

Zepp Health is currently undergoing a cyclical demand adjustment phase, optimizing costs to maintain profitability. The shift in the EV/Sales ratio demonstrates this process, with the current mark standing at 584.48. This trend is driven by the company's leadership in creating Amazfit wearable gadgets with proprietary software, as well as the monetization of cloud services and the sale of biometric sensors.

Huami Corporation (ZEPP) - Company Value to Revenue from 11/23/2025 to 11/19/2026

Financial and market metric breakdowns for Zepp Health Corporation (ZEPP)

- price and consensus price forecast:
Fundamental company valuation:ZEPP, huami.com
Product sample of huami.com

Zepp Health (ZEPP) competes in the wearable electronics segment, where intense pricing pressure limits margins. Under these conditions, the company's EV/Sales ratio allows for a valuation of the business, including debt, relative to its generated revenue stream. This metric determines the market value of one dollar of sales, excluding the influence of capital structure. Low values may signal an undervaluation or a systemic decline in demand. Analyzing the trend on this chart helps distinguish an investment opportunity from a "value trap."